Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat Hes1 ELISA Kit (AC2416)
Cat.#: ASET-1005
Specifications
Description Rat Hes1 ELISA Kit allows for the in vitro quantitative determination of rat Hes1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1859 Human G-Protein Coupled Receptor 30 ELISA Kit (AC3270) Quantitative inquiry ASET-2489 Rat EAAT1 ELISA Kit (AC3900) Quantitative inquiry ASET-1216 Mouse VEGFC ELISA Kit (AC2627) Quantitative inquiry ASET-2129 Human Hyaluronan Synthase 2 ELISA Kit (AC3540) Quantitative inquiry ASET-1632 Rat CaSR ELISA Kit (AC3043) Quantitative inquiry ASET-1975 Human SOX6 ELISA Kit (AC3386) Quantitative inquiry ASET-1670 Human Histidine Decarboxylase ELISA Kit (AC3081) Quantitative inquiry ASET-1144 Human Neuroglobin ELISA Kit (AC2555) Quantitative inquiry ASET-1702 Rat CysLT2 ELISA Kit (AC3113) Quantitative inquiry ASET-1258 Human PCDH1 ELISA Kit (AC2669) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket